Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elke Schueler"'
Autor:
João Pedro Ferreira, Javed Butler, Faiez Zannad, Gerasimos Filippatos, Elke Schueler, Dominik Steubl, Cordula Zeller, James L. Januzzi, Stuart Pocock, Milton Packer, Stefan D. Anker
Publikováno v:
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2022, 79 (12), pp.1129-1137. ⟨10.1016/j.jacc.2022.01.029⟩
Journal of the American College of Cardiology, Elsevier, 2022, 79 (12), pp.1129-1137. ⟨10.1016/j.jacc.2022.01.029⟩
BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) may be beneficial in reducing heart failure (HF) hospitalizations in patients with HF with preserved ejection fraction. The effect of sodium-glucose cotransporter 2 inhibitors in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ed232ee953e5391021db677ddb1d7a
https://hal.univ-lorraine.fr/hal-03620257/document
https://hal.univ-lorraine.fr/hal-03620257/document
Autor:
João Pedro Ferreira, Faiez Zannad, Javed Butler, Gerasimos Filippatos, Stuart J. Pocock, Martina Brueckmann, Dominik Steubl, Elke Schueler, Stefan D. Anker, Milton Packer
Publikováno v:
JAMA Cardiology. 7:1148
ImportanceAlbuminuria, routinely assessed as spot urine albumin-to-creatinine ratio (UACR), indicates structural damage of the glomerular filtration barrier and is associated with poor kidney and cardiovascular outcomes. Sodium-glucose cotransporter-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6b980d20e719bee067124457e50c8a7
https://doi.org/10.1001/jamacardio.2022.2924
https://doi.org/10.1001/jamacardio.2022.2924
Autor:
Anne Pernille Ofstad, Silvio E. Inzucchi, Bernard Zinman, Elke Schueler, Sabine Kahl, Christoph Wanner, Michael Roden
Publikováno v:
Diabetes. 70
Treatment with empagliflozin (EMPA) improves cardiorenal outcomes, but also reduces liver fat content in individuals with both type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD). Thus, we evaluated the effects of EMPA vs. placebo (PLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::723115712d32216a53bf1998c8fc0b31
https://doi.org/10.2337/db21-319-or
https://doi.org/10.2337/db21-319-or
Autor:
Faiez Zannad, Waheed Jamal, Martina Brueckmann, Stefan D. Anker, João Pedro Ferreira, Gerasimos Filippatos, Milton Packer, Stuart J. Pocock, Elke Schueler, Javed Butler, Dominik Steubl
Publikováno v:
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2021, 77 (11), pp.1397-1407. ⟨10.1016/j.jacc.2021.01.044⟩
Journal of the American College of Cardiology, Elsevier, 2021, 77 (11), pp.1397-1407. ⟨10.1016/j.jacc.2021.01.044⟩
Background Mineralocorticoid receptor antagonists (MRAs) and sodium glucose co-transporter 2 inhibitors favorably influence the clinical course of patients with heart failure and reduced ejection fraction. Objectives This study sought to study the mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a7bc4edf0c864a19c7e6fd610dd06c
https://hal.univ-lorraine.fr/hal-03185873/document
https://hal.univ-lorraine.fr/hal-03185873/document
Autor:
João Pedro, Ferreira, Faiez, Zannad, Stuart J, Pocock, Stefan D, Anker, Javed, Butler, Gerasimos, Filippatos, Martina, Brueckmann, Waheed, Jamal, Dominik, Steubl, Elke, Schueler, Milton, Packer
Publikováno v:
Journal of the American College of Cardiology. 77(11)
Mineralocorticoid receptor antagonists (MRAs) and sodium glucose co-transporter 2 inhibitors favorably influence the clinical course of patients with heart failure and reduced ejection fraction.This study sought to study the mutual influence of empag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f12af90f72f233e59bab1a55e27a3dc8
https://pubmed.ncbi.nlm.nih.gov/33736822
https://pubmed.ncbi.nlm.nih.gov/33736822
Autor:
Samuel Z. Goldhaber, Stefan Hantel, Ajay J. Kakkar, Sebastian Schellong, Henry Eriksson, Elke Schueler, Sam Schulman, Jörg Kreuzer, Martin Feuring
Publikováno v:
Journal of Thrombosis and Thrombolysis. 43:484-489
The direct oral anticoagulants, e.g., dabigatran etexilate (DE), are effective and well tolerated treatments for venous thromboembolism (VTE). Net clinical benefit (NCB) is a useful concept in weighing potential benefits against potential harm of com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74da6423257793962a8e925ab8612ad2
https://doi.org/10.1007/s11239-017-1479-z
https://doi.org/10.1007/s11239-017-1479-z
Autor:
Martin, Feuring, Sam, Schulman, Henry, Eriksson, Ajay J, Kakkar, Sebastian, Schellong, Stefan, Hantel, Elke, Schueler, Jörg, Kreuzer, Samuel Z, Goldhaber
Publikováno v:
Journal of Thrombosis and Thrombolysis
The direct oral anticoagulants, e.g., dabigatran etexilate (DE), are effective and well tolerated treatments for venous thromboembolism (VTE). Net clinical benefit (NCB) is a useful concept in weighing potential benefits against potential harm of com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::885427aed0e2d8c29aaae0050d1a40fa
https://pubmed.ncbi.nlm.nih.gov/28210989
https://pubmed.ncbi.nlm.nih.gov/28210989
Autor:
Mandy Fraessdorf, Henry Eriksson, Martin Feuring, Sam Schulman, Samuel Z. Goldhaber, Ajay K. Kakkar, Elke Schueler, Sebastian Schellong, Joerg Kreuzer
Publikováno v:
Vascular medicine (London, England). 21(6)
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to compare dabigatran etexilate with warfarin for the treatment and prevention of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b35726a122bcba4715b58d88dabb1a
https://pubmed.ncbi.nlm.nih.gov/27807306
https://pubmed.ncbi.nlm.nih.gov/27807306